EP3463357
(2S)-1-[4-(3,4-DICHLOROPHENYL)PIPERIDIN-L-YL]-3-[2-(5-METHYL-L,3,4-OXADIAZOL-2-YL)BENZO[B]FURAN-4-YLOXY]PROPAN-2-OL OR ITS METABOLITE FOR TREATING ANXIETY DISORDERS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
23.5.2017EP published:
20.9.2023EP application number:
17729263.8
EPO information:
European Patent Register
Max expiry date:
22.5.2037
Title in English:
(2S)-1-[4-(3,4-DICHLOROPHENYL)PIPERIDIN-L-YL]-3-[2-(5-METHYL-L,3,4-OXADIAZOL-2-YL)BENZO[B]FURAN-4-YLOXY]PROPAN-2-OL OR ITS METABOLITE FOR TREATING ANXIETY DISORDERSLanguage of the patent:
English
Timeline
Today
23.5.2017EP application
20.9.2023EP Publication
Owner
Name:
Minerva Neurosciences, Inc.Address:
1601 Trapelo Road, Suite 284, Waltham, MA 02451, US
Inventor
Name:
LUTHRINGER, RemyAddress:
1204 Geneva, CH
Priority
Number:
201662341517 PDate:
25.5.2016Country:
US
Number:
201662373720 PDate:
11.8.2016Country:
US
Classification
Categories:
A61K 31/454, A61P 25/22